Navigation Links
Westaim commences mailing of management information circular and announces new director


TORONTO, March 1 /PRNewswire-FirstCall/ - The Westaim Corporation (Westaim or the Company) (TSX: "WED") announces that it has distributed proxy materials to its transfer agent and intermediaries for mailing to registered and beneficial shareholders in connection with a special meeting of shareholders to be held on March 25, 2010 for the purpose of approving the issuance of up to 550 million common shares of the Corporation issuable upon the conversion of (i) 254 million class A subscription receipts and (ii) 296 million class B subscription receipts (together the Subscription Receipts). The proxy materials consist of a form of proxy and a management information circular dated as of February 26, 2010 (the Circular). The Circular contains details of, among other things, the sale of the Subscription Receipts undertaken by Westaim in order to finance the purchase price in respect of its previously announced acquisition (the Acquisition) of JEVCO Insurance Company (JEVCO), the terms of the Acquisition, the business of JEVCO and certain historical and pro forma financial information relating to JEVCO and Westaim. The form of proxy and Circular (including certain financial information and related MD&A relating to JEVCO) will be available on SEDAR ( and the Corporation's web page (

Westaim also announces the appointment of Mr. Brian Gibson as a director of the Corporation. Mr. Gibson is Senior Vice President, Public Equities of the Alberta Investment Management Corporation (AIMCo). AIMCo is an Alberta crown corporation which is responsible for managing and investing funds on behalf of certain Alberta public sector pension plans, endowments and government funds. It is expected that AIMCo will identify a second nominee prior to or shortly after the completion of the Acquisition.

"We welcome Brian to the Westaim Board and look forward to working with him to complete the Acquisition and integration of JEVCO's business," said Cameron MacDonald, Westaim's President and Chief Executive Officer. "AIMCo has been instrumental in enabling Westaim to pursue the Acquisition and we expect the knowledge and experience of Mr. Gibson to be an important asset for Westaim's Board going forward."

About Westaim

Westaim invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

Certain portions of this press release as well as other public statements by Westaim, contain forward-looking statements. Such forward-looking statements include but are not limited to statements concerning the transactions described herein; investment strategies and expected rates of return; and strategic alternatives to maximize value for shareholder. These statements are based on current expectations that are subject to risks, uncertainties and assumptions and Westaim can give no assurance that these expectations are correct. Westaim's actual results could differ materially from those anticipated by forward-looking statements for various reasons generally beyond our control, including but not limited to: (i) failure to complete the Acquisition; (ii) changes in market conditions or deterioration in underlying investments; (iii) general economic, market, financing, regulatory and industry developments and conditions; and (iv) other risk factors set forth in the Circular, Westaim's Annual Report or Annual Information Form. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

SOURCE Westaim Corporation

Back to top
SOURCE Westaim Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim announces 2009 third quarter results
2. Westaim announces 2009 second quarter results
3. Westaim announces 2009 first quarter results
4. Westaim enters into Management Services Agreement
5. Westaim announces 2008 year-end results
6. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
7. Westaim announces 2008 third quarter results
8. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
9. Westaim terminates reorganization agreement and cancels shareholders meeting
10. Westaim to deregister its common stock in the United States
11. Westaim announces sale of iFire Technology Ltd. assets
Post Your Comments:
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... -- The Biotechnology industry might still be ... opportunities to investors. assesses the recent performances of ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... complimentary trade alerts at: ...
(Date:6/23/2016)... , June 23, 2016 Leading BioSciences ... address medical conditions resulting from a breakdown of ... appointed Greg Doyle as chief executive ... BioSciences, executive management team and board of directors, ... financial officer. He will provide continued leadership and ...
Breaking Medicine Technology: